Gilead Sciences
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.zydelig.comRevenue
$5.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Gilead Sciences
Gilead Sciences, Inc. produces ZYDELIG (idelalisib), a prescription medication specifically designed for treating adults with chronic lymphocytic leukemia (CLL) in combination with Rituxan (rituximab). Their target clients include patients whose CLL has relapsed after prior treatments and who may have additional health complications preventing them from using Rituxan alone. The company emphasizes the importance of monitoring for serious side effects during treatment and provides extensive resources for patient support and advocacy. Gilead Sciences is committed to ensuring safe and effective therapy for their clients while addressing potential safety concerns associated with the use of ZYDELIG.Explore more
Popular SearchesGilead Sciences IncZydeligSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gilead Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Gilead Sciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Gilead Sciences
Earning: See what the market has to say on Gilead Sciences recently announced quarterly report
Gilead Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Gilead Sciences had a recent Job posting/layoffs
Check if Gilead Sciences has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Gilead Sciences launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Gilead Sciences has new funding data
Recommended Actions
Find VP level buyers at Gilead Sciences
Find more new buyers
Compare Similar Companies to Gilead Sciences
Compare insights from companies similar to Gilead Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Gilead Sciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Gilead Sciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gilead Sciences.
Gilead Sciences Tech Stack
A closer look at the technologies used by Gilead Sciences
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gilead Sciences
Sign Up For FreeTo access detailed company insights
Gilead Sciences, Inc. produces ZYDELIG (idelalisib), a prescription medication specifically designed for treating adults with chronic lymphocytic leukemia (CLL) in combination with Rituxan (rituximab). Their target clients include patients whose CLL has relapsed after prior treatments and who may have additional health complications preventing them... Read More
